| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | AP endonuclease 1 ELISA Kit; AP endonuclease class I ELISA Kit; AP lyase ELISA Kit; APE 1 ELISA Kit; APE ELISA Kit; APE-1 ELISA Kit; APEN ELISA Kit; APEX 1 ELISA Kit; APEX ELISA Kit; APEX nuclease (multifunctional DNA repair enzyme) 1 ELISA Kit; Apex nuclease 1 ELISA Kit; APEX nuclease ELISA Kit; APEX1 ELISA Kit; APEX1_HUMAN ELISA Kit; Apurinic endonuclease ELISA Kit; Apurinic-apyrimidinic endonuclease 1 ELISA Kit; Apurinic/apyrimidinic (abasic) endonuclease ELISA Kit; Apurinic/apyrimidinic endonuclease 1 ELISA Kit; Apurinic/apyrimidinic exonuclease ELISA Kit; APX ELISA Kit; BAP1 ELISA Kit; Deoxyribonuclease (apurinic or apyrimidinic) ELISA Kit; DNA (apurinic or apyrimidinic site) lyase ELISA Kit; DNA-(apurinic or apyrimidinic site) lyase; mitochondrial ELISA Kit; EC 4.2.99.18 ELISA Kit; HAP 1 ELISA Kit; HAP1 ELISA Kit; Human Apurinic endonuclease 1 ELISA Kit; MGC139790 ELISA Kit; Multifunctional DNA repair enzyme ELISA Kit; Redox factor 1 ELISA Kit; Redox factor-1 ELISA Kit; REF 1 ELISA Kit; REF 1 protein ELISA Kit; REF-1 ELISA Kit; REF1 ELISA Kit; REF1 protein ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, tissue homogenates, cell lysates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
DNA-(apurinic or apyrimidinic site) lyase (APEX1) is a biological molecule commonly studied in others research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: P27695
Biological context
Researchers often monitor DNA-(apurinic or apyrimidinic site) lyase (APEX1) in serum, plasma, tissue homogenates, and cell lysates to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in DNA-(apurinic or apyrimidinic site) lyase (APEX1) may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, DNA-(apurinic or apyrimidinic site) lyase (APEX1) may also appear under names such as AP endonuclease 1 and AP endonuclease class I. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that DNA-(apurinic or apyrimidinic site) lyase (APEX1) participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Clinical Significance of Apurinic/Apyrimidinic Endodeoxyribonuclease 1 and MicroRNA Axis in Hepatocellular Carcinoma
G Mangiapane,Journal of Clinical and Translational Hepatology,2023
Distinct circulating cytokine/chemokine profiles correlate with clinical benefit of immune checkpoint inhibitor monotherapy and combination therapy in advanced non-small cell lung cancer
Y Hu,Cancer medicine,2023